ASTHMA sufferers have been told to check their inhalers after two brands have issued an urgent recall. Here's what you need to know to work out if you need to pass your puffer back. Two brands have ...

Around 6,000 inhalers used by asthma patients have been recalled by health officials. Asthma UK said that ‘faulty inhalers could put people’s lives at risk’ as it called on patients to check whether ...

Thousands of inhalers used by asthma patients have been recalled over safety fears. Asthma UK said that "faulty inhalers could put people's lives at risk" as it called on patients to check whether ...

A SMALL tear could help identify if your asthma inhaler is one of thousands recalled amid fears thousands are “putting sufferers’ lives at risk”. Two brands of inhalers have been found to be faulty, ...

Seretide/Advair is GSK’s best-selling drug, and the line was extended in 2003 when the European Union approved the higher-dose 500 Accuhaler for the symptomatic treatment of severe COPD, i.e., ...

The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...

The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...